WB
XBI icon

WesBanco Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

WesBanco Bank’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,345
Closed -$244K – 548
2023
Q3 		$244K Buy
+3,345
New +$267K 0.01% 516

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

WesBanco Bank's XBI Position: Q4 2023 in Review

WesBanco Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 3,345 shares — an estimated $244K sold.

WesBanco Bank first reported a position in XBI in Q3 2023 and held it in 1 quarter. The position peaked at $244K in Q3 2023. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

  • WesBanco Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
  • WesBanco Bank sold 3,345 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $244K.
  • WesBanco Bank first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and held it in 1 quarter.
  • WesBanco Bank's State Street SPDR S&P Biotech ETF position peaked at $244K in Q3 2023.
  • 745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on WesBanco Bank's 13F filing for Q4 2023, filed 16 Feb 2024.